Antimicrobial Composition for Throat Pathogenesis Prevention
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for sore throats often fail to effectively prevent the initial stage of pathogenesis, where viral infections create conditions for bacterial adherence and biofilm formation, leading to upper and lower respiratory tract infections.
Innovation Solution
An antimicrobial composition comprising free fatty acids, carboxylic acids, and carbohydrates, which exhibit antiviral, antibacterial, and anti-adhesion properties, inhibiting microbial adhesion to throat tissue and exerting a potent microbicidal effect on microbial cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional treatments are used for sore throats, then symptomatic relief may be provided, but they fail to effectively prevent the initial stage of pathogenesis where viral infections create conditions for bacterial adherence and biofilm formation
Solution Approach 1:
The invention segments the antimicrobial action into three distinct functional components: (1) anti-adhesion agents (carbohydrates and free fatty acids) that prevent initial microbial attachment, (2) microbicidal agents (carboxylic acids and free fatty acids) that kill established microbes, and (3) soothing agents that provide symptomatic relief. This segmentation allows each component to target a specific stage of pathogenesis, thereby resolving the contradiction between reliability in prevention and adaptability to multiple pathological stages.
Solution Approach 2:
The invention employs a composite formulation combining multiple types of active ingredients with different mechanisms of action: carbohydrates (e.g., xylitol, sucrose), free fatty acids (e.g., caprylic acid, capric acid), and carboxylic acids (e.g., citric acid, lactic acid). This composite approach enables the single composition to simultaneously address viral infections, bacterial adherence, and biofilm formation, thereby achieving both high reliability in prevention and versatility across multiple pathogenesis stages.
2Ease of operation
If a composition targets only symptomatic relief, then patient comfort is improved, but the underlying cause of infection and the initial stage of pathogenesis remain untreated
Solution Approach 1:
The invention applies preliminary action by incorporating anti-adhesion agents (carbohydrates and free fatty acids) that prevent microbial attachment before infection can establish. This preliminary protective barrier acts prophylactically against the initial stage of pathogenesis, while the composition simultaneously provides symptomatic relief through its soothing components, thereby resolving the contradiction between ease of operation for symptom relief and reliability for infection prevention.
Solution Approach 2:
The composition achieves universality by designing a multi-functional formulation that simultaneously: (1) provides anti-adhesion activity to prevent microbial colonization, (2) exerts microbicidal effects to kill pathogens, and (3) soothes throat symptoms. This multi-functionality allows a single product to address both symptomatic relief and infection prevention, resolving the contradiction between ease of operation and reliability.
3Reliability
If free fatty acids with longer chain lengths are used, then antiviral and antibacterial properties are enhanced, but solubility and ease of formulation become more difficult
Solution Approach 1:
The invention applies parameter changes by carefully selecting free fatty acids with chain lengths of 6-10 carbon atoms, with optimal performance at 8-10 carbons. This specific parameter range balances two opposing requirements: longer chains provide enhanced antimicrobial efficacy while maintaining sufficient solubility in aqueous or semi-aqueous formulations. The invention thus resolves the contradiction between reliability (antimicrobial efficacy) and ease of manufacture (solubility) by optimizing the chain length parameter within a specific range.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition effectively prevents microbial adhesion and colonization, reducing the risk of infections by inhibiting bacterial growth and biofilm formation, as demonstrated by its strong antiviral and antibacterial properties and anti-adhesion effects.
Implementation Method 1
The carbohydrate as well as the free fatty acid block the adhesion of the bacterial cells to the throat tissue and therefore exhibit good anti-adhesion properties
Implementation Method 2
The free fatty acid and carboxylic acid exerts a potent microbicidal effect on contact with a microbial cell by dissolution of the lipid components of the microbial cell membrane
Data Source
Figure 1~2
Figure 3~4
AI summary
The present invention relates to an antimicrobial composition comprising at least one free fatty acid or a derivative and/or a pharmaceutically acceptable salt thereof, wherein the free fatty acid is selected from a free fatty acid having from 6 to 16 carbon atoms, at least one carboxylic acid or a pharmaceutically acceptable salt thereof and/or at least one carbohydrate or a pharmaceutically acceptable salt thereof, wherein the carbohydrate is selected from a hydrogenated carbohydrate, a monosaccharide, a disaccharide, a polysaccharide and combinations thereof. The antimicrobial composition of the present inventions provides enhanced anti-adhesion and /or disinfecting properties. The composition of the present invention can be formulated into a drink, gel or spray suitable for treating or preventing the first stage in pathogenesis.